logo

You are here

Warning message

Attention! This event has already passed.

Feasibility, safety and immunogenicity of a dendritic cell-based immunotherapeutic approach in HIV-1-infected patients

Monday, 17 September, 2012 - 17:00
Campus: Brussels Health Campus
Faculty: Medicine and Pharmacy
auditorium R. Vanden Driessche
Sabine Allard
phd defence

 

Openbare doctoraatsverdediging van Sabine Allard voor het behalen van de graad van Doctor in de Medische Wetenschappen met het proefschrift getiteld: 'Feasibility, safety and immunogenicity of a dendritic cell-based immunotherapeutic approach in HIV-1-infected patients'.

Attachment: 
PDF icon Allard_i.pdf